RhumbLine Advisers
INBX

RhumbLine Advisers’s Inhibrx, Inc. Common Stock INBX Stock Holding History

RhumbLine Advisers’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-51,485
Closed -$1.8M – 4431
2024
Q1 		$1.8M Buy
51,485
+2,338
+5% +$85.3K ﹤0.01% 1951
2023
Q4 		$1.87M Buy
49,147
+322
+0.7% +$6.9K ﹤0.01% 1945
2023
Q3 		$896K Sell
48,825
-1,344
-3% -$28.1K ﹤0.01% 2270
2023
Q2 		$1.3M Buy
50,169
+5,611
+13% +$131K ﹤0.01% 2160
2023
Q1 		$841K Buy
44,558
+3,354
+8% +$78K ﹤0.01% 2205
2022
Q4 		$1.01M Buy
41,204
+5,661
+16% +$166K ﹤0.01% 2122
2022
Q3 		$638K Buy
35,543
+2,699
+8% +$48.7K ﹤0.01% 2380
2022
Q2 		$373K Buy
32,844
+4,435
+16% +$65.2K ﹤0.01% 2641
2022
Q1 		$633K Buy
28,409
+3,299
+13% +$84.2K ﹤0.01% 2313
2021
Q4 		$1.1M Buy
25,110
+702
+3% +$28.1K ﹤0.01% 2170
2021
Q3 		$813K Buy
24,408
+2,431
+11% +$74K ﹤0.01% 2329
2021
Q2 		$605K Buy
+21,977
New +$458K ﹤0.01% 2480
2021
Q1 		– Sell
-6,490
Closed -$214K – 3075
2020
Q4 		$214K Buy
+6,490
New +$173K ﹤0.01% 2811

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

RhumbLine Advisers's INBX Position: Q2 2024 in Review

RhumbLine Advisers sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 51,485 shares — an estimated $1.8M sold.

RhumbLine Advisers first reported a position in INBX in Q4 2020 and held it in 13 quarters. The position peaked at $1.87M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • RhumbLine Advisers reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 51,485 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $1.8M.
  • RhumbLine Advisers first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
  • RhumbLine Advisers's Inhibrx, Inc. Common Stock position peaked at $1.87M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.